CA-7-FOR-ALL-MANKIND
7 For All Mankind, in collaboration with Jaunt and ELLE announce the release of Visions of California , a groundbreaking 3D virtual reality experience. This collaboration marks the first time a fashion brand has utilized virtual reality to share an imaginative narrative of their collection--affording consumers a unique opportunity to fully immerse themselves into 7 For All Mankind’s creative point of view. The silhouettes for spring and the brand’s California-centric spirit can be seen through a 360-degree perspective. Visions of California is available, starting today, on Google Play for Google Cardboard and Android phones. Moreover, Visions of California will be coming soon to select iOS devices in the Apple App Store.
Virtual Reality is exploding and is more accessible than ever. The medium is the ideal vehicle for 7 For All Mankind to convey their spring brand story. Filmed in Paris against the backdrop of a French chateau, Visions of California engages the viewer in a sweeping experience, allowing the brand to connect them to a California state of mind, no matter where they are in the world. The Golden State fantasy takes consumers on a vivid journey while simultaneously letting them appreciate the key shapes, fit, and wearability of the 7 For All Mankind spring collection.
“7 For All Mankind has always been a pioneer in the fashion industry,” said Barry Miguel, President of 7 For All Mankind. “We were first to market in the premium denim category, leaders in debuting technologically advanced fabrics and fit solutions, and now, a trailblazer for creating such a breakthrough method for how our customers experience our product.”
Jaunt, the company pioneering cinematic virtual reality, captured Visions of California with their proprietary 360 degree, stereoscopic 3D cameras and advanced 3D sound-field microphones, that gives viewers a convincing, high-quality sense of “presence.” In addition, ELLE, the first fashion brand to collaborate with Jaunt in 2014, teamed up with 7 For All Mankind to bring Visions of California to life and will promote the content across their digital platforms.
“Visions of California is a perfect example of how brands and content creators can come together to reach their audiences in engaging new ways, and this film showcases just how powerful storytelling in VR can be,” said Jens Christensen, CEO of Jaunt.
“ELLE's collaboration with 7 For All Mankind and Jaunt on this VR project exemplifies the innovative ways we build out creative concepts and content with our partners,” said SVP & Publisher of ELLE, Kevin O’Malley. “It also reflects the growing convergence of media, fashion, and technology.”
Custom Pop Up VR viewers, designed by DODOcase, will be sent to a select number of ELLE subscribers and 7 For All Mankind customers. Fans of the denim brand will also have the chance to view the VR experience in person and get the limited edition viewer at 7 For All Mankind boutiques in the following locations: Santa Monica, San Diego, Aventura, and San Francisco in California, and at the SoHo store in New York.
To download, visit: www.7forallmankind.com/experience
To view the 2D version and access the embed code click here
About 7 For All Mankind®
7 For All Mankind®, a division of VF Contemporary Brands, Inc., is the world’s premiere brand of denim-lifestyle products. Founded in 2000, the Los Angeles based premium denim brand quickly earned critical acclaim due to its innovations in fit, fabric and finish. The 7 For All Mankind® brand offers denim, sportswear and accessories collections for men, women and kids. Products are sold in freestanding 7 For All Mankind® stores, on-line at www.7ForAllMankind.com , and in luxury department and specialty stores in over 80 countries worldwide. VF Contemporary Brands, Inc., is a wholly-owned subsidiary of VF Corporation. For more information about VF, please visit their website: www.vfc.com . For more information about the 7 For All Mankind® brand, please visit: www.7ForAllMankind.com
About Jaunt
Jaunt is developing the hardware, software, tools, and applications to enable cinematic VR and put the power of virtual reality in the hands of today’s best content creators. Jaunt’s algorithms for complex computational photography allow content producers to create incredible immersive 360 degree, stereoscopic 3-D, cinematic VR experiences using existing production software. The company’s investors include Highland Capital Partners, Google Ventures, Redpoint Ventures, Peter Gotcher, Blake Krikorian, and British Sky Broadcasting (corporate.sky.com ). Experience more at www.jauntvr.com , or follow Jaunt on Twitter and Instagram (@jauntvr), or Facebook (facebook.com/jauntvr ).
About ELLE
ELLE is the No. 1 fashion magazine brand in the world, with 46 editions, 34 websites, and more than 200 supplements worldwide. The ELLE U.S. brand reaches over 26 million influential readers, users, fans and followers across all platforms and inspires women to explore, cultivate and celebrate their personal style in all aspects of their lives. For more information visit ELLE.com , or follow ELLE on Twitter (@ELLEmagazine), Facebook (facebook.com/ELLEmagazine ), Google+ (plus.google.com/+ELLE ), Instagram (@ELLEUSA), Pinterest (pinterest.com/ELLE ), or Tumblr (ELLE.tumblr.com ).
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150413006359/en/
Contact:
7 For All Mankind
Timothy Flach, 646-839-5432
PR Manager
Timothy_Flach@vfc.com
or
On
Behalf of 7 For All Mankind
Karen Sayah, 310-415-1919
karensayah@gmail.com
or
SutherlandGold
Group for Jaunt
Victoria Butler, 415-848-7178
jaunt@sutherlandgold.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum